MLEC | Moolec Science SA Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.6980 - 0.7900
52 Week Range	0.5300 - 3.25
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	16,074
Average Volume	18,225
Shares Outstanding	38,470,700
Market Cap	30,007,146
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-03-02

Valuation
Profitability
Growth
Health
P/E Ratio	-3.90
Forward P/E Ratio	N/A
EPS	-0.20
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	52
Country	Luxembourg
Website	MLEC

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

MLEC's peers: MSSTF, AAGH, MCURF, JANX, INDP, RZLT, TPST, CMRA, FBRX, NUVB, LYEL, IPSC, GBIO, STTK, MLYS, CVKD, GPCR, CNTA, NVCT, MLECW

*Chart delayed

Analyzing fundamentals for MLEC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see MLEC Fundamentals page.

Watching at MLEC technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on MLEC Technicals page.